GLP-1 Half-Life Visualizer
Select a medication and slide to any day to see the estimated drug level remaining in your system. Based on FDA-published half-life data. Educational tool — not medical advice.
t½ = 7 days — dosing every 7 days
Estimated Serum Level — Day 3
Concentration Decay Curve
Half-life data source: FDA Wegovy Prescribing Information §12.3
How This Works
Select Your Medication
Choose from semaglutide, tirzepatide, or liraglutide. Each has a distinct half-life from the FDA label.
Set Days Since Injection
Drag the slider to match how many days have passed since your last injection.
Read the Level
The tool estimates what percentage of the peak dose is still circulating, using the standard exponential decay formula.
Understand the Zones
Green = active range. Yellow = declining, next dose approaching. Red = near washout, minimal activity expected.
Half-Life Reference
| Drug | Half-life | Dosing | Days to ~10% remaining | Source |
|---|---|---|---|---|
| Semaglutide | ~7 days (168 h) | Once weekly | ~23 days | FDA Wegovy §12.3 |
| Tirzepatide | ~5 days (116 h) | Once weekly | ~16 days | FDA Zepbound §12.3 |
| Liraglutide | ~13 hours | Once daily | ~1.8 days | FDA Saxenda §12.3 |
Half-life values reflect mean population estimates from FDA prescribing information. Individual values vary by body weight, renal function, and other factors.
What Does Half-Life Mean?
What is a drug half-life?
Why does semaglutide stay in the body so long?
Does a lower level mean the drug stopped working?
Is this tool telling me what my actual blood level is?
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.